On August 5, 2020, ORIENT BIO Inc. (KOSE:A002630) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
525 KRW | -0.19% |
|
+1.35% | -13.51% |
1st Jan change | Capi. | |
---|---|---|
-13.51% | 44.94M | |
+20.17% | 126B | |
+24.67% | 118B | |
+23.41% | 27.87B | |
-17.74% | 20.95B | |
-15.55% | 16.92B | |
-15.21% | 16.18B | |
+11.91% | 14.84B | |
-47.10% | 14.79B | |
+54.50% | 14.08B |
- Stock Market
- Equities
- A002630 Stock
- News ORIENT BIO Inc.
- ORIENT BIO Inc. announced that it has received KRW 11.67259512 billion in funding from MDAS Inc., Orient Precision Industries Inc.